Clinical efficacy and safety of mirabegron and imidafenacin in women with overactive bladder: A randomized crossover study (the MICRO study)
出版年份 2016 全文链接
标题
Clinical efficacy and safety of mirabegron and imidafenacin in women with overactive bladder: A randomized crossover study (the MICRO study)
作者
关键词
-
出版物
NEUROUROLOGY AND URODYNAMICS
Volume 36, Issue 4, Pages 1097-1103
出版商
Wiley
发表日期
2016-06-06
DOI
10.1002/nau.23050
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada
- (2015) Adrian Wagg et al. CUAJ-Canadian Urological Association Journal
- Persistence with mirabegron therapy for overactive bladder: A real life experience
- (2015) Nisha Pindoria et al. NEUROUROLOGY AND URODYNAMICS
- Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder
- (2014) Osamu Yamaguchi et al. BJU INTERNATIONAL
- Is there seasonal variation in symptom severity, uroflowmetry and frequency–volume chart parameters in men with lower urinary tract symptoms?
- (2014) Rufus Cartwright et al. SCOTTISH MEDICAL JOURNAL
- Comparative Efficacy and Safety of Medical Treatments for the Management of Overactive Bladder: A Systematic Literature Review and Mixed Treatment Comparison
- (2013) Khaled Maman et al. EUROPEAN UROLOGY
- Prevalence and factors associated with xerostomia and hyposalivation among community-dwelling older people in Japan
- (2013) Yuki Ohara et al. GERODONTOLOGY
- Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience
- (2012) Adrian Wagg et al. BJU INTERNATIONAL
- Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
- (2012) Christopher R. Chapple et al. EUROPEAN UROLOGY
- Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline
- (2012) E. Ann Gormley et al. JOURNAL OF UROLOGY
- Long-Term Safety and Efficacy of Two Different Antimuscarinics, Imidafenacin and Solifenacin, for Treatment of Overactive Bladder: A Prospective Randomized Controlled Study
- (2012) Teruhiko Yokoyama et al. UROLOGIA INTERNATIONALIS
- Relationship between Toe Temperature and Lower Urinary Tract Symptoms
- (2012) Hiroo INOUE et al. LUTS-Lower Urinary Tract Symptoms
- Selective Binding of Bladder Muscarinic Receptors in Relation to the Pharmacokinetics of a Novel Antimuscarinic Agent, Imidafenacin, to Treat Overactive Bladder
- (2010) S. Yamada et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Patient-reported reasons for discontinuing overactive bladder medication
- (2009) Joshua S. Benner et al. BJU INTERNATIONAL
- A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder
- (2009) Yukio Homma et al. INTERNATIONAL JOURNAL OF UROLOGY
- The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis
- (2008) Christopher R. Chapple et al. EUROPEAN UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started